Archives
-
BglII Restriction Endonuclease Overview
2026-10-03
BglII (SKU K3010) is a supplier-described restriction endonuclease for research applications involving DNA that contains the 5′-AGATCT-3′ recognition sequence. No matched paper or independent performance evidence was provided.
-
miR-24-3p Modulates Doxorubicin-Induced Heart Failure
2026-10-02
The reference study identifies miR-24-3p as a direct regulator of Sp1 and links its activity to PI3K signaling in doxorubicin-induced heart failure. Using rat and H9c2 cell models, the authors show that miR-24-3p silencing reduces apoptosis and oxidative stress, although translation beyond these experimental systems remains unresolved.
-
Deep Learning of USC Mitochondria in Alzheimer’s
2026-10-01
A 2025 Neurotherapeutics study combined live urine-derived stem cell mitochondrial imaging with ResNet-18 classification to identify morphology patterns associated with Alzheimer’s disease and mild cognitive impairment. The approach offers a non-invasive route for studying systemic mitochondrial phenotypes, but larger independent cohorts and functional validation are still needed before clinical use.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-10-01
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide solubilizer for screening poorly soluble hydrophobic compounds, especially molecules containing aromatic or phenyl groups. It is appropriate for pharmaceutical and biochemical research workflows as a drug formulation excipient or solubility aid, but the dossier does not establish universal bioavailability improvement, clinical use, or suitability for unrelated applications.
-
BglII Restriction Endonuclease: Practical Guide
2026-09-30
BglII Restriction Endonuclease (SKU K3010) is designed for rapid cleavage of plasmid DNA, PCR products, and genomic DNA that contain the AGATCT recognition site. Use it for research workflows with a known target sequence and predicted digest pattern; it is not intended for diagnostic or medical applications.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-09-30
This scenario-driven guide explains how HRP Goat Anti-Mouse IgG (H+L) Antibody, SKU K1221, can strengthen orthogonal protein detection in cell viability, proliferation, and cytotoxicity studies. It covers assay compatibility, optimization, interpretation, storage, and practical vendor-selection criteria.
-
Mithramycin A: A Transcriptional Stress-Test Tool
2026-09-29
Mithramycin A is an anticancer antibiotic that provides a mechanistically distinct way to interrogate G-C-rich transcriptional programs. This article connects its DNA-binding pharmacology with the miR-24-3p/Sp1/PI3K findings in doxorubicin cardiac injury while defining practical assay boundaries.
-
SGI-1027: Translational Leverage in Cancer Epigenetics
2026-09-29
SGI-1027 illustrates how DNA methyltransferase inhibition can move beyond promoter demethylation toward coordinated control of tumor suppressor gene reactivation, lysosomal membrane permeability, apoptosis, and pyroptosis. This thought-leadership perspective translates the evidence into practical study-design guidance for researchers investigating renal cancer and broader cancer epigenetics.
-
Chloramphenicol for Plasmid Selection Workflows
2026-09-28
Chloramphenicol combines tunable selection pressure with a well-defined 50S ribosome mechanism for plasmid maintenance, transformation screening, and engineered transfer assays. This workflow-focused guide connects routine molecular biology selection with recent evidence on carbapenemase-gene mobility while clearly separating plasmid selection from clinical resistance interpretation.
-
Bardoxolone Methyl: Redox Mechanisms & Research Use
2026-09-28
Bardoxolone methyl, also called CDDO methyl ester, is a research compound reported to activate KEAP1–Nrf2 signaling and inhibit NF-kB signaling. This article separates those compound-specific findings from a 2024 study connecting thioredoxin-dependent redox control of ribonucleotide reductase to CHK1 inhibitor sensitivity in lung cancer cells.
-
TaqI Restriction Endonuclease: Practical Guide
2026-09-27
TaqI Restriction Endonuclease (SKU K3053) is a sequence-specific enzyme for rapid digestion of plasmid DNA, PCR products, and genomic DNA at TCG A recognition sites. It supports research workflows such as cloning and DNA analysis, but is not intended for diagnostic or medical use.
-
Mithramycin A Workflows for Cancer Biology Research
2026-09-26
Use Mithramycin A to probe how G-C-rich DNA regulation shapes c-myc expression and myeloid cell phenotypes. This practical guide pairs a cautious dose-and-time pilot with controls that help distinguish transcriptional effects from general cytotoxicity.
-
Diminazene Aceturate: A Context-Dependent Research Probe
2026-09-25
Diminazene Aceturate is best interpreted as a context-dependent research probe, not as a single-purpose mechanistic answer. This article examines how to distinguish its trypanocidal use from ACE2-related findings, assess the strength of the evidence, and design more informative experiments.
-
SGI-1027 Workflows for DNA Methylation Research
2026-09-25
Use SGI-1027 to probe DNMT-dependent methylation and tumor suppressor gene reactivation, while separating growth arrest from actual cell killing. A staged workflow pairs dose and time courses with methylation, expression, protein, and viability readouts so epigenetic effects are not mistaken for general toxicity.
-
CCCP and Mitochondrial Image Assay Interpretation
2026-09-24
CCCP (carbonyl cyanide m-chlorophenyl hydrazine) disrupts the mitochondrial proton gradient, but its effects should not be confused with a direct readout of mitochondrial shape or disease. Learn how to interpret CCCP perturbations alongside deep-learning analysis of urine-derived stem cells and Alzheimer’s disease research.